United Services Automobile Association Supernus Pharmaceuticals, Inc. Transaction History

United Services Automobile Association

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$25.47 - $33.37 $489,355 - $641,137	-19,213 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$29.96 - $38.87 $58,392 - $75,757	-1,949 Reduced 9.21%	19,213 $636,000
Q1 2019 May 13, 2019	BUY	$32.77 - $41.99 $6,619 - $8,481	202 Added 0.96%	21,162 $742,000
Q4 2018 Feb 13, 2019	SELL	$30.84 - $49.51 $575,011 - $923,113	-18,645 Reduced 47.08%	20,960 $696,000
Q3 2018 Nov 13, 2018	SELL	$42.7 - $56.55 $571,326 - $756,639	-13,380 Reduced 25.25%	39,605 $1.99 Million
Q2 2018 Aug 10, 2018	SELL	$44.1 - $59.85 $2 Million - $2.71 Million	-45,308 Reduced 46.09%	52,985 $3.17 Million
Q1 2018 May 14, 2018	BUY	$37.15 - $46.9 $431,720 - $545,024	11,621 Added 13.41%	98,293 $4.5 Million
Q4 2017 Feb 14, 2018	BUY	$36.4 - $42.6 $1.03 Million - $1.21 Million	28,382 Added 48.69%	86,672 $3.45 Million
Q3 2017 Nov 14, 2017	BUY	$36.75 - $49.65 $2.14 Million - $2.89 Million	58,290	58,290 $2.33 Million

282

60.9M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $1.94B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.